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Echinacea-induced cytosolic Ca2+ elevation in HEK293
Abstract
Background: With a traditional medical use for treatment of various ailments, herbal preparations of
Echinacea are now popularly used to improve immune responses. One likely mode of action is that alkamides
from Echinacea bind to cannabinoid type 2 (CB2) receptors and induce a transient increase in intracellular
Ca2+. Here, we show that unidentified compounds from Echinacea purpurea induce cytosolic Ca2+ elevation
in non-immune-related cells, which lack CB2 receptors and that the Ca2+ elevation is not influenced by
alkamides. Methods: A non-immune human cell line, HEK293, was chosen to evaluate E. purpurea root
extracts and constituents as potential regulators of intracellular Ca2+ levels. Changes in cytosolic Ca2+ levels
were monitored and visualized by intracellular calcium imaging. U73122, a phospholipase C inhibitor, and
2-aminoethoxydiphenyl borate (2-APB), an antagonist of inositol-1,4,5-trisphosphate (IP3) receptor, were
tested to determine the mechanism of this Ca2+ signaling pathway. E. purpurea root ethanol extracts were
fractionated by preparative HPLC, screened for bioactivity on HEK293 cells and by GC-MS for potential
constituent(s) responsible for this bioactivity. Results: A rapid transient increase in cytosolic Ca2+ levels
occurs when E. purpurea extracts are applied to HEK293 cells. These stimulatory effects are phospholipase C
and IP3 receptor dependent. Echinacea-evoked responses could not be blocked by SR 144528, a specific CB2
receptor antagonist, indicating that CB2 is not involved. Ca2+ elevation is sustained after the Echinacea-
induced Ca2+ release from intracellular Ca2+ stores; this longer-term effect is abolished by 2-APB, indicating
a possible store operated calcium entry involvement. Of 28 HPLC fractions from E. purpurea root extracts, six
induce cytosolic Ca2+ increase. Interestingly, GC-MS analysis of these fractions, as well as treatment of
HEK293 cells with known individual and combined chemicals, indicates the components thought to be
responsible for the major immunomodulatory bioactivity of Echinacea do not explain the observed Ca2+
response. Rather, lipophilic constituents of unknown structures are associated with this bioactivity.
Conclusions: Our data indicate that as yet unidentified constituents from Echinacea stimulate an IP3 receptor
and phospholipase C mediation of cytosolic Ca2+ levels in non-immune mammalian cells. This pathway is
distinct from that induced in immune associated cells via the CB2 receptor.
Disciplines
Biochemistry, Biophysics, and Structural Biology | Cell Biology | Genetics | Kinesiology
Comments
This is an article from BMC Complementary and Alternative Medicine 10 (2010): 1, doi:10.1186/
1472-6882-10-72. Posted with permission.
Rights
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Authors
Lankun Wu, Eric W. Rowe, Ksenija Jeftinija, Srdija Jeftinija, Ludmila Rizhsky, Basil Nikolau, Jodi McKay,
Marian L. Kohut, and Eve Wurtele
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/bbmb_ag_pubs/62
RESEARCH ARTICLE Open Access
Echinacea-induced cytosolic Ca2+ elevation in
HEK293
Lankun Wu1,2, Eric W Rowe3, Ksenija Jeftinija3, Srdija Jeftinija3, Ludmila Rizshsky2,4, Basil J Nikolau2,4, Jodi McKay5,
Marian Kohut2,6, Eve Syrkin Wurtele1,2*
Abstract
Background: With a traditional medical use for treatment of various ailments, herbal preparations of Echinacea are
now popularly used to improve immune responses. One likely mode of action is that alkamides from Echinacea
bind to cannabinoid type 2 (CB2) receptors and induce a transient increase in intracellular Ca2+. Here, we show
that unidentified compounds from Echinacea purpurea induce cytosolic Ca2+ elevation in non-immune-related cells,
which lack CB2 receptors and that the Ca2+ elevation is not influenced by alkamides.
Methods: A non-immune human cell line, HEK293, was chosen to evaluate E. purpurea root extracts and
constituents as potential regulators of intracellular Ca2+ levels. Changes in cytosolic Ca2+ levels were monitored
and visualized by intracellular calcium imaging. U73122, a phospholipase C inhibitor, and 2-aminoethoxydiphenyl
borate (2-APB), an antagonist of inositol-1,4,5-trisphosphate (IP3) receptor, were tested to determine the mechanism
of this Ca2+ signaling pathway. E. purpurea root ethanol extracts were fractionated by preparative HPLC, screened
for bioactivity on HEK293 cells and by GC-MS for potential constituent(s) responsible for this bioactivity.
Results: A rapid transient increase in cytosolic Ca2+ levels occurs when E. purpurea extracts are applied to HEK293
cells. These stimulatory effects are phospholipase C and IP3 receptor dependent. Echinacea-evoked responses could
not be blocked by SR 144528, a specific CB2 receptor antagonist, indicating that CB2 is not involved. Ca2+
elevation is sustained after the Echinacea-induced Ca2+ release from intracellular Ca2+ stores; this longer-term effect
is abolished by 2-APB, indicating a possible store operated calcium entry involvement. Of 28 HPLC fractions from E.
purpurea root extracts, six induce cytosolic Ca2+ increase. Interestingly, GC-MS analysis of these fractions, as well as
treatment of HEK293 cells with known individual and combined chemicals, indicates the components thought to
be responsible for the major immunomodulatory bioactivity of Echinacea do not explain the observed Ca2+
response. Rather, lipophilic constituents of unknown structures are associated with this bioactivity.
Conclusions: Our data indicate that as yet unidentified constituents from Echinacea stimulate an IP3 receptor and
phospholipase C mediation of cytosolic Ca2+ levels in non-immune mammalian cells. This pathway is distinct from
that induced in immune associated cells via the CB2 receptor.
Background
Well known for its characteristic fiery and pungent
taste, Echinacea produces local anesthesia of the
mucous membranes; thus, it has been used medicinally
since ancient times [1]. Echinacea was used by Native
Americans as a remedy to treat a number of ailments;
principally in relation to the alleviation of pain and the
promotion of healing, in cases of snake bites, burns,
cough, sore throats, and toothache [1]. Echinacea pro-
ducts are currently promoted as general enhancers of
the immune system, and are among the top-selling her-
bal preparations in the U.S.A [2]. Despite the popularity
of Echinacea as an herbal supplement, and many phar-
macological and clinical studies, the molecular mechan-
isms of action for Echinacea are not well understood.
Among the phytochemicals that accumulate in Echina-
cea [2,3], four major classes, polyunsaturated alkamides/
ketones, caffeic acid derivatives, glycoproteins, and poly-
saccharides, exhibit biological effects in vitro and
in vivo. These include anti-inflammatory, anti-fungal,
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anti-viral, and immunostimulatory activities [1,4,5].
However, it is uncertain which specific compound(s) are
primarily responsible for these bioactivities, or whether
they are efficacious in humans [4]. Furthermore, the
early molecular events associated with cellular exposure
to Echinacea are unknown.
Recently, a possible mode of action for Echinacea was
proposed based on indications that some alkamides bind
to cannabinoid (CB) receptors in vitro [6,7]; the concen-
trations of alkamides required for binding to the CB2
receptor, as reported by different groups, have differed
by as much as 30-fold (60 nM, [6]; 2-20 μM, [7]). More
recently, these alkamides, as well as crude E. purpurea
extracts, were reported to transiently induce intracellular
calcium (Ca2+) levels in HL60 cells via CB2 receptor
activation [8].
Because of Ca2+’s central role as a key intracellular
second messenger mediating diverse range of cellular
processes [9], and because so little is understood about
the early events associated with Echinacea-induced
bioactivity, we postulate that metabolic components
from this genus may induce intracellular Ca2+ increase,
which could mediate a series of physiological process
involved in this bioactivity.
To evaluate the possibility that Echinacea components
impact Ca2+ homeostasis, the effects of applying Echina-
cea extracts and HPLC-purified fractions from these
extracts were studied in HEK293 cells using intracellular
calcium imaging. The HEK293 line was chosen because
of its nature as a human non-immune cell line, its well-
characterized transcriptome and the apparent absence of
CB receptors [10].
Methods
Plant Material and Extraction and Preparative HPLC
Fractionation
Plant materials were provided by the USDA North Cen-
tral Regional Plant Introduction Station (NCRPIS, Ames,
IA). E. purpurea (accession PI631307) was used in all
experiments. Further information about this accession
can be found on the Germplasm Resources Information
Network database at http://www.ars grin.gov/npgs/acc/
acc_queries.html.
Echinacea extracts were prepared from roots of
2-year-old field grown plants, soxhlet ethanol extraction
and preparative HPLC fractionation of the extracts were
performed as previously described [11]. All extracts and
fractions were dried and re-dissolved in 100% DMSO
and diluted 1000 times with HEPES buffer (final con-
centration of DMSO is 0.1%) before applied to the cells.
GC-MS Analysis
GC-MS analysis was used to determine concentrations
of known alkamides present in E. purpurea fractions
through the use of synthetic standards as previously
described [11].
Chemicals
Fura-2 AM, pluronic F-127, Dulbecco’s modified Eagle’s
Medium, penicillin-streptomycin, L-glutamine, and tryp-
sin were purchased from Invitrogen (Carlsbad, CA,
USA); thapsigargin, 2-aminoethoxydiphenyl borate (2-
APB), 1-[6-[((17b)-3-Methoxyestra-1,3,5[10]-trien-17-yl)
amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) and 1-[6-
[((17b)-3-Methoxyestra-1,3,5[10]-trien-17-yl)amino]
hexyl]-2,5-pyrrolidinedione (U-73343) were purchased
from Sigma (St. Louis, MO, USA). SR 144528 was gen-
erously provided by NIDA Drug Supply System (Balti-
more, MD, USA). Alkamide and ketone standards were
synthesized as previously described [11].
Cell Culture
HEK293 cells were obtained from ATCC (Manassas,
VA, USA) and cultured in Dulbecco’s modified Eagle’s
Medium supplemented with 10% FBS, 50 U/ml penicil-
lin, 50 μg/ml streptomycin, and 2 mM glutamine. Cells
were grown in an incubator at 37°C with humidified 5%
CO2 and 95% air.
Intracellular Calcium Imaging
Intracellular calcium concentrations ([Ca2+]i) were mea-
sured by ratiometric imaging techniques using a perfu-
sion system as previously described [12]. Cells were
plated onto 22-mm microscope coverslips 36 hr before
the experiment. Cells were loaded with Fura 2-AM for
60 min at room temperature. The loading solution con-
tained 1 μl of 25% (w/w) Pluronic F-127 and 4 nM of
Fura 2-AM diluted in 1 ml of HEPES buffer. The load-
ing solution was removed and the cells were washed
twice with HEPES buffer before the coverslips were
placed onto a perfusion chamber and connected to a
micro pump. The test chemicals were placed in syringes
on a five-valve manifold and added into the perfusion
chamber using a micro pump with a flow rate of 200 μl
per min. The application lengths of Echinacea extracts,
fractions and chemicals were indicated by the bars on
the graph as well as in the figure legends. As a result of
the physical distance between the syringe and the cell
chamber, there was a 2 min delay between adding the
test or control samples and the exposure of the cells to
the samples. Initial analysis of calcium imaging data was
conducted using MetaFluor® software. Maximum
increase in [Ca2+]i (Δ[Ca
2+]iMax) was determined as the
difference from the resting value to the maximum
response. The time-to-peak value was measured and
defined as the time it took for the signal to reach from
the resting value to the maximum response. The
response length was defined as the time interval from
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the time the signal reaches the maximum response to
the time it took to return to the resting value. The
dose-response curve was generated using PRISM 4.02
(GraphPad Software, San Diego, CA, US). The half-max-
imum concentration of Echinacea extract that induces a
response (EC50) was calculated from the fitted sigmoidal
curves using PRISM 4.02.
Statistical Analysis
The cytosolic [Ca2+] increase data (Δ[Ca2+]i) were repre-
sented as mean ± SEM, n = 3; data were compiled from
cell traces from three biological replicates (three inde-
pendent cell cultures), measuring at least 20 cell traces/
replicate; each value is the mean of ≤ 20 cells from one
replicate. Means of Δ[Ca2+]iMax were analyzed by t-test
to determine statistical significance compared to the
control. One-way analysis of variance followed by the
Tukey test was also carried out to compare means
between different treatments. All statistical analyses
were performed using SAS software version 9.1 (SAS
Institute Inc., Cary, NC).
Results
E. purpurea extracts induce transient cytosolic [Ca2+]
increase in HEK293 cells
Roots of E. purpurea are among those most widely used
medicinally [4], thus we focused on this species, using a
well-characterized accession (PI631307) grown and pro-
cessed under defined conditions [3].
E. purpurea root ethanol extracts evoke a transient
[Ca2+]i increase in HEK293 cells (Figure 1A). This Echi-
nacea-evoked calcium response returns to baseline
rapidly after removal of the Echinacea extract (Figure
1A), indicating that the activation is reversible. At a
dose of 100 μg extract/ml, the increase of [Ca2+]i was 71
± 4 nM, and the time-to-peak of this response was 32 ±
2 s. A second application of extract induces a second
transient increase in [Ca2+]i of somewhat less intensity
than the first. Similar attenuation of the response to sec-
ond application of the ligands has been previously
demonstrated and was determined to be due to receptor
desensitization [13] Similarly prepared ethanol extracts
of an non-Echinacea species, spinach, were tested as a
control, no [Ca2+]i increase was observed (Figure 1B).
To investigate the concentration-dependence of this
Echinacea response, seven concentrations of extracts,
ranging from 25 to 300 μg/ml, were evaluated (Figure 2).
At concentrations as low as 50 μg/ml, E. purpurea
extract evokes a transient increase in [Ca2+]i; the
response saturates at about 200 μg/ml, with an EC50 of
98 ± 7 μg/ml (n = 3). Transient [Ca2+]i increases were
also induced with similarly prepared extracts from
E. pallida, E. angustifolia and E. tennesseensis (data not
shown).
Evaluation of potential constituents that induce the [Ca2+]i
response
To begin identifying the constituent(s) responsible for indu-
cing this transient increase of cytosolic [Ca2+]i, E. purpurea
extracts were fractionated using preparative HPLC. Twenty-
eight fractions were collected and tested for bioactivity.
Aliquots of the HPLC fractions were applied to HEK293
cells at levels proportional to their concentrations in the
initial ethanol extract. In this HPLC protocol, phenolics
such as cichoric acid and cholorogenic acid elute in the
more polar fractions (retention times of about 2-40 min),
whereas Bauer alkamides 1, 2, 3, 4, 8, 9, 10, 11 and Chen
alkamide elute in the later less polar fractions (retention
times of 49-94 min) [3]. Six of the E. purpurea fractions
(fractions #68, #72, #75, #80, #83 and #94) are active in
evoking [Ca2+]i elevation in HEK293; the other 22 fractions
have no detectable bioactivity (Figure 3). Both the duration
and intensity of the transient [Ca2+]i increase are unique to
each bioactive fraction (Figure 4). Among the six active frac-
tions, fraction #72 has the highest activity based on the peak
height of intracellular calcium concentration (Figure 3).
The constituents of each HPLC fraction were finger-
printed by GC-MS; three of these are shown in Figure
4. In addition to numerous non-alkamide constituents,
fraction #68 contains Bauer alkamides 1, 2, 4, 6 and
Chen alkamide; fraction #72 contains Bauer alkamides 4,
8/9, 10 and Chen alkamide; fraction #75 contains Bauer
alkamides 8/9 and 10; fractions #80 and #94 contain
Bauer alkamides 8/9, 10 and 11 and fraction #83 con-
tains Bauer alkamides 8/9 and 11 (Table 1).
Synthesized standards of Bauer alkamides 8, 10, 11, and
Bauer ketone 23 were tested for bioactivity in the intracellu-
lar Ca2+ assay. Bauer alkamide 11 was of particular interest
because it has been reported by Raduner et al. [6] to bind
to the cannabinoid receptor, CB2. None of these pure com-
pounds display detectable bioactivity on HEK293 when
applied individually, and even when applied at concentra-
tions up to 8-fold higher than their concentrations found in
the E. purpurea extracts (data not shown). Taken together,
these results indicate that lipophilic constituents of yet uni-
dentified structures are associated with the induction of
[Ca2+]i increase in HEK293 cells by Echinacea. These
responsible bioactive constituent(s) could be novel or alter-
nately they might be identified in other plant species but
not yet found in E. purpurea; for example, in E. pallida
non-polar ketones such as pentadeca-(8 Z,13 Z)-dien-11-
yn-2-one have been recently identified in E. pallida [14].
Echinacea-induced [Ca2+]i increases in HEK293 cells
appear to be associated with release of Ca2+ from IP3-
sensitive intracellular stores, and this process may involve
PLC activation
Two principal sources of Ca2+ affect the concentration
of cytosolic Ca2+: internal Ca2+ stores, primarily in the
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endoplasmic reticulum (ER), and extracellular Ca2+. To
examine whether the observed Echinacea-induced tran-
sient [Ca2+]i increase depends on external calcium,
HEK293 cells were perfused either with HEPES solution
supplemented with normal concentrations of calcium
(2 mM) or with EDTA-chelated calcium-free HEPES
buffer for 10 min, before treatment with E. purpurea
extracts. In both of these sets of experiments the Echi-
nacea-induced transient increase in [Ca2+]i was observed
(Figure 5A). Therefore, the source of the transient [Ca2
+]i increase in the Echinacea-treated HEK293 cells
appears to be from intracellular stores, as indicated by
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Figure 1 E. purpurea root ethanol extracts induce a transient increase in cytosolic Ca2+ concentrations in HEK293 cells. (A) Left: Real-
time monitoring of the change in cytosolic Ca2+ concentrations in HEK293 cells in response to repeated application of E. purpurea (Ech) extract
(100 μg/ml). Δ[Ca2+]iMax = 71 ± 4 nM (mean ± SEM, n = 3). Time-to-peak = 32 ± 2 s (mean ± SEM, n = 3). This Echinacea-evoked increase in
cytosolic Ca2+ concentration was statistically significant (p < 0.001) as compared to the control cells, which were treated with 1% DMSO
(dissolved in HEPES buffer). Right: Pseudocolor images of calcium concentration in cells before treatment (control) and after treatment with E.
purpurea extract. (B) Left: Real-time monitoring of the change in cytosolic Ca2+ in HEK293 cells in response to application of spinach extract (200
μg/ml), and then a subsequent application of E. purpurea extract (100 μg/ml). Right: Pseudocolor images of calcium concentration in cells before
treatment (control), after treatment with spinach extract, and after treatment with E. purpurea extract. E. purpurea and spinach extracts were
prepared with 95% ethanol [11], dried, and re-dissolved in 100% DMSO and diluted 1000 times with HEPES buffer (final concentration of DMSO
is 0.1%) before applied to the cells for 2 min (the bar in the graph represents the application length). Data is an average trace of the treatment
of at least 20 cells in each experiment, representative of three independent experiments.
Wu et al. BMC Complementary and Alternative Medicine 2010, 10:72
http://www.biomedcentral.com/1472-6882/10/72
Page 4 of 13
Figure 2 Dose-response curve of the transient increase in cytosolic Ca2+ concentration in HEK293 cells evoked by E. purpurea root
ethanol extracts. Results are expressed as percentages of maximum responses. Each data point represents mean ± SEM, n = 3 replicates. EC50
= 98 ± 7 μg/ml. The response saturates at 200 μg/ml of extract. The Hill equation was used to fit the response curve.
Figure 3 Fractionation by preparative HPLC of the Ca2+-inducing activity in E. purpurea root ethanol extracts. HPLC-separated fractions
from 95% ethanol extract of E. purpurea root induce significantly different levels of Ca2+ response. Fraction numbers refer to the time (in
minutes) when each fraction eluted from the HPLC column. Bar graphs show the mean values of the transient increase in cytosolic Ca2+
concentration evoked by different fractions (mean ± SEM, n = 3, from three independent experiments). There was no detectable response from
fractions #2-67 and fraction #87. Different letters indicate statistically significant differences (p < 0.05) between the cytosolic Ca2+ increase of the
six active fractions by one-way analysis of variance followed by the Tukey test.
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the stimulatory effect that occurs despite the cells being
in calcium-free media.
Release of Ca2+ from internal ER-stores typically
occurs via an inositol-1,4,5-trisphosphate (IP3) receptor,
however, other mechanisms exist as well [15]. We tested
for the possible involvement of the IP3 receptor in the
Echinacea-induction of intracellular Ca2+ release by
evaluating the effect of 2-aminoethoxydiphenyl borate
(2-APB), an IP3 receptor antagonist, on Echinacea-
induced cytosolic Ca2+ increase. If Echinacea-extracts
induce intracellular Ca2+ via an IP3 receptor, blocking
this receptor should eliminate the Echinacea-induced
increase in [Ca2+]i. 2-APB (100 μM) completely
abolishes the transient increase in [Ca2+]i evoked by the
Echinacea-extract (Figure 5B), consistent with the role
of the IP3 receptor in mediating bioactivity.
To test whether phospholipase C (PLC) activation is
required for the Echinacea-induced increase in [Ca2+]i,
the effects of U-73122, a specific PLC inhibitor, and its
inactive analog U-73343 were evaluated. In these
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Figure 4 Different HPLC-separated fractions of E. purpurea root ethanol extract produce different effects on transient increase in the
concentration of cytosolic Ca2+ in HEK293 cells. Three example traces are shown. (Statistical analysis of data from all fractions is presented in
Figure 3.) Left: Average traces from the treatment of at least 20 cells per experiment, representative of three independent experiments. Fractions
were applied according to their effects in the initial trials. For each of the bioactive fractions, the increase in cytosolic Ca2+ concentration was
statistically significant as compared to 1% DMSO control treatment (p < 0.001). Right: GC-MS chromatograms of metabolites in these three
fractions; chemically identifiable metabolites are labelled. Inactive fractions (e.g., fraction #67), were also applied after active fractions to confirm
that the particular HEK293 culture used was indeed responsive to Echinacea extracts. The exposure time to each fraction is 2 min.
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studies, the HEK293 cell cultures were treated with
Echinacea extracts first, to show that the cultures were
indeed able to respond to Echinacea. The PLC antago-
nist, or its inactive analog, was then applied for 10 min
and the Echinacea extract was reapplied to test whether
there are any blocking effects of the antagonist. Applica-
tion of U-73122 completely abolishes the increase in
[Ca2+]i that is evoked by the Echinacea-extract (Figure
5C), whereas U-73343 has no such effect (Figure 5D),
consistent with an involvement of the PLC pathway.
Thapsigargin and 2-ABP inhibition experiments indicate
that Echinacea extract may induce Ca2+ influx by
activating SOCE following depletion of Ca2+ from
intracellular stores
To experimentally evaluate whether store operated cal-
cium entry (SOCE) plays a role in calcium homeostasis
in the HEK293 cell response to Echinacea-extracts,
external Ca2+ was removed and internal Ca2+ stores
were depleted using the sarcoplasmic/ER Ca2+ -ATPase
(SERCA) pump inhibitor, thapsigargin. Restoration of
external Ca2+ following thapsigargin-treatment indicates
the function of SOCE, which can be observed as an
increase in cytosolic Ca2+ [16]. Here, the effect of thap-
sigargin is compared to the effect of Echinacea extract.
The Ca2+ responses evoked by Echinacea and thapsigar-
gin are similar (Figure 6). In the absence of extracellular
Ca2+, both agents evoke a transient intracellular Ca2+
elevation, interpreted as being due to Ca2+ release from
internal stores. After Ca2+-containing medium is intro-
duced, a sustained increase in cytosolic Ca2+ is observed
for both treatments (Figure 6A, 6B). This pattern is
consistent with SOCE-mediated changes in the concen-
tration of cytosolic Ca2+ [16].
To examine whether thapsigargin- and Echinacea-
induced Ca2+ entry pathways are pharmacologically simi-
lar in the HEK model, 2-APB was applied in the contin-
ued presence of external Ca2+. 2-APB is considered the
most potent and consistent compound in blocking
SOCE, acting as a potent SOCE inhibitor independent of,
and in addition to, its ability to inhibit the IP3 receptor
[17]. 2-APB has no effect on voltage-operated Ca2+ chan-
nels [18] or on non-voltage-activated Ca2+ entry path-
ways [19]. Therefore, despite its dual effects, 2-APB
provides a critical reagent for investigating SOCE activa-
tion and for discriminating between different forms of
Ca2+ entry [17]. 100 μM 2-APB completely blocks SOCE
induced by both thapsigargin and Echinacea extracts
(Figure 6C, 6D). This result is consistent with the invol-
vement of an SOCE pathway in the Ca2+ elevation asso-
ciated with Echinacea-induced depletion of Ca2+ from
intracellular stores.
CB2 is not involved in Echinacea-induced [Ca2+]i increase
in HEK293 cells
CB2 was not detected in HEK293 cells in multiple
microarray studies of HEK293 [10]; over 200 public
microarray data in ArrayExpress at http://www.ebi.ac.
uk/microarray-as/ae/]. Due to a mounting interest in CB
as a potential target for Echinacea action [6-8], we also
tested the ability of SR 144528, a specific CB2 receptor
antagonist, to effect the Echinacea-induced [Ca2+]I
increase. In these studies, SR 144528 (100 μM) was
applied for 10 min and then the Echinacea extract (100
Table 1 GC-MS analysis of identified compounds in the 6 bioactive fractions of E. purpurea root extract a
Fraction 68 Fraction 72 Fraction 75 Fraction 80 Fraction 83 Fraction 94
Compound % by Dry
Weight
μM % by Dry
Weight
μM % by Dry
Weight
μM % by Dry
Weight
μM % by Dry
Weight
μM % by Dry
Weight
μM
Bauer
alkamide 1
+2
2.8 0.41 Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd
Chen
alkamide
11.5 1.56 2.8 2.38 Nd Nd Nd Nd Nd Nd Nd Nd
Bauer
alkamide 10
Nd Nd 1.2 1 15.1 0.19 0.4 0.01 Nd Nd 0.8 1.33
Bauer
alkamide 11
Nd Nd Nd Nd Nd Nd 6.7 0.13 11.2 0.74 6.5 10.7
Bauer
alkamide 8
+9
Nd Nd 41.9 35.32 46.9 0.61 2.5 0.05 4.6 0.31 1.8 3.01
Bauer
alkamide 4
11.5 1.56 Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd
Bauer
alkamide 6
5.1 0.66 Nd Nd Nd Nd Nd Nd Nd Nd Nd Nd
a The chemical identification of these alkamides in this E. purpurea accession, and the systematic chemical nomenclature for these alkamides have been
previously described [3]. All identified constituents were confirmed via GC-MS with synthetic standards. Nd: not detectable.
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μg/ml) was applied to test whether there are any block-
ing effects of the antagonist. Our results showed that SR
144528 was not able to abolish the Echinacea response
(Figure 7). This confirmed that CB2 was indeed not
responsible for the Echinacea-induced [Ca2+]i elevation
observed in HEK293 cells.
Discussion
Despite numerous reports on physiological and cellular
consequences of treatments with Echinacea [4,11,19],
little is known about the early molecular mechanisms
that might mediate these events. One possibility is that
Echinacea acts in part via Ca2+, a central intracellular
messenger that participates in the regulation and co-
regulation of inflammation [20] and pain [21]. A recent
report describes an increase in Ca2+ in HL60 cells that
is induced by alkamides of Echinacea, and mediated
via the CB2 receptor [8]. Here, we describe an effect of
Echinacea components in a non-immune-related cell
type that lacks CB2 receptors. Based on these data, we
reveal an Echinacea-induced stimulation of an increase
in cytosolic Ca2+ that is not-CB2-dependent, and is
not associated with the major alkamides of E.
purpurea.
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Figure 5 Transient increase in cytosolic Ca2+ concentration in HEK293 cells induced by E. purpurea root ethanol extracts is associated
with Ca2+ release from the IP3-sensitive intracellular store and the PLC pathway. (A) Kinetic changes of [Ca
2+]i in HEK cells in response to
repeated applications of Echinacea extract (100 μg/ml) in normal (2 mM Ca2+) and Ca2+-free (EDTA-chelated) solution. Removal of Ca2+ from
media does not affect the Echinacea-evoked response when compared to the control (without Ca2+ removal) (p < 0.001), indicating the
response may be associated with the release of internal Ca2+ stores; (B) Transient increase in cytosolic Ca2+ concentration evoked by Echinacea
can be abolished by 10 min pretreatment of cells with 100 μM of 2-APB, an IP3 receptor antagonist; this effect was significant (p < 0.001) as
compared to the control (without pretreatment by 2-APB); (C) Transient increase in cytosolic Ca2+ concentration evoked by Echinacea can be
abolished by a 10 min pretreatment of cells with 2 μM U73122, a PLC inhibitor, indicating PLC may be required for the response; this effect is
significant (p < 0.001) as compared to the control (without treatment by U73122). (D) Transient increase in cytosolic Ca2+ concentration evoked
by Echinacea cannot be abolished by a 10 min pretreatment with 2 μM U73343, an inactive analog of U73122. The effect of U73343 was not
significant (p > 0.05) when compared to the control (without treatment of U73343). Echinacea treatment time in this set of experiments was 2
mins. Data are average traces of at least 20 cells in one experiment representative of three independent experiments.
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This Echinacea-induced Ca2+ influx of HEK293 cells is
likely associated with an IP3 mediated signaling pathway
(Figure 8). Ca2+ influx is rapid, does not require external
Ca2+ and is eliminated by the IP3 receptor antagonist, 2-
APB. Furthermore, the PLC pathway may play a role in
this release, as suggested by the observation that the
Echinacea-evoked increase in cytosolic Ca2+ is blocked
by the PLC antagonist U-73122, but not by its inactive
analog (U-73343).
A PLC-dependent signal might be mediated in several
ways. For example, constituents of Echinacea might bind
to a surface membrane receptor that is coupled to PLC,
such as chemokine [22], glutamate [23], or purinergic
receptors [24]. Microarray data indicate these receptors are
present in HEK293 cells [10]. The observation that active
fractions of the E. purpurea extract have differential kinetic
properties and potency on HEK293 cells (e.g., bioactive
HPLC-fractions #80 and #83) is consistent with more than
one receptor being stimulated by Echinacea extracts. A
second possibility is that bioactive constituent(s) enter the
cell and act directly or via an intracellular moiety on PLC.
These possibilities are not mutually exclusive. Because a
portion of the Ca2+ response that is induced by Echinacea
extracts is associated with lipophilic constituent(s), logical
candidates for being permeable across cell membranes
[25], we can not exclude this possibility.
Calcium stored in the ER is released through Ca2+
channels in the ER membrane, usually via the IP3 recep-
tor or ryanodine receptor families [15]. Ca2+ pumps
located in the ER membranes then return cytosolic Ca2+
into the lumen, thus contributing to Ca2+ homeostasis
between the cytoplasm and ER. The intracellular Ca2+
stores are refilled from the extracellular reservoir, mostly
through SOCE [16]. SOCE has been reported in multi-
ple cell types, e.g., smooth muscle cells, epithelial cells,
hippocampal cells, and regulates physiological processes
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Figure 6 Echinacea -evoked depletion of Ca2+ from intracellular stores induced Ca2+ influx via SOCE in HEK293 cells. This response is
pharmacologically similar to the Ca2+ influx evoked by thapsigargin. (A) Top: After depletion of Ca2+ stores by treating cells with 2 μM
thapsigargin in Ca2+-free conditions for 10 min, 2 mM Ca2+ was added to assess SOCE; Bottom: Ten min after restoration of external Ca2+, 100
μM 2-APB was applied for 10 mins; (B) Top: After depletion of Ca2+ stores by treating cells with Echinacea extract (100 μg/ml) in Ca2+-free
conditions for 10 min, 2 mM Ca2+ was added to assess SOCE; Bottom: Ten min after restoration of external Ca2+, 100 μM 2-APB was applied for
10 mins. Data shown are average traces of at least 20 cells in one experiment representative of three independent experiments.
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such as inflammation, cardiac contraction, and neuro-
transmission [26].
Our data indicate that the source of the initial transi-
ent increase in cytosolic calcium levels that are induced
by Echinacea-extracts is from internal stores, indicative
of a metabotropic response. In this metabotropic model,
PLC activation would lead to the production of IP3,
which in turn would activate the IP3 receptor causing
release of Ca2+ from the ER [15]. The participation of
the IP3 receptor in the Echinacea-induced calcium
release is suggested by treatment of HEK293 cells with
the specific membrane-permeable IP3 receptor antago-
nist, 2-APB [17]. 2-APB is able to completely abolish
the Echinacea-induced calcium release from internal
stores. 2-APB has been reported to enhance leakage of
Ca2+ from the ER and inhibit SERCA activity, resulting
in enhancement of Ca2+ signaling [27]. This complex
action of 2-APB is consistent with the small initial intra-
cellular calcium increase we observed in HEK293 cells
after 2-APB application.
This model predicts that the Echinacea-induced release
of Ca2 from internal stores may be coupled to a subse-
quent activation of the SOCE process. In many cell types,
depletion of intracellular Ca2+ stores results in the opening
of SOCE in the plasma membrane [16]. SOCE, thought to
mediate aspects of cell secretion and motility, cell prolif-
eration and gene expression by altering cellular Ca2+ [16],
is considered a promising target for therapeutic treatment
in inflammatory diseases [28]. The nature of SOCE, and
the mechanism linking Ca2+-store content to the opening
of this Ca2+ channel, remains unclear. Two proteins have
been implicated in SOCE function: Orai1, a pore-forming
subunit of the SOCE, and stromal interaction molecule 1
(STIM1), thought to be an ER-based Ca2+ sensor that acti-
vates SOCE by an as yet undefined mechanism [16].
Therefore we propose that the resultant decrease of Ca2+
in ER after Echinacea treatment would in turn activate the
plasma membrane SOCE through a mechanism that
involves STIM1. Taken together, this model predicts that
in HEK293 cells, the level of cytosolic Ca2+ associated with
Echinacea treatment increases through two mechanisms:
initially the release of Ca2+ from ER Ca2+ stores, and sub-
sequently Ca2+ influx via SOCE.
The physiological events downstream of a cytosolic Ca2+
increase, whether Echinacea-induced or otherwise, are
complex and highly dependent on the cell type and con-
text in which they occur. Longer range effects of changes
in cytosolic levels of Ca2+ regulate a wide variety of cellular
processes [20]. In T-cells, for example, elevated intracellu-
lar Ca2+ activate Ca2+-dependent enzymes, such as calci-
neurin, and thereby transcription factors, such as nuclear
factor of activated T cells (NFAT) and nuclear factor-B
(NF-B). These transcription factors modulate the activa-
tion of T-cells and generation of cytokines, which in turn
regulate the expression of many target genes in inflamma-
tion and pain transmission [20].
Studies using animal and human models indicate that
Echinacea extracts enhance the cyclooxygenase 2 and
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Figure 7 Transient increase in cytosolic Ca2+ concentration evoked by Echinacea extracts is not mediated by CB2 receptor activation.
Echinacea extract (100 μg/ml)-evoked cytosolic Ca2+ transients in HEK293 cells (exposure time was 2 mins) cannot be abolished by a 10 min
pretreatment with the specific CB2 receptor antagonist SR 144528 (100 μM). The effect of SR 144528 was not significant (p > 0.05) when
compared to the control (without treatment of SR 144528). Data are average traces of at least 20 cells in one experiment representative of three
independent experiments.
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Figure 8 Proposed metabotropic mechanism for Ca2+ signaling in HEK293 cells underlying the modulation of some of the cellular
responses induced by Echinacea extracts. Green arrows indicate steps proposed from data in this paper. Purple lines indicate inhibitors used
in this study. In this model, lipophilic constituents in Echinacea extracts bind to unidentified surface membrane receptor(s) (R), resulting in the
activation of PLC. PLC-activation catalyzes the production of IP3 from PIP2. IP3 binds to and opens IP3R in the membrane of the ER, resulting in
the release of Ca2+ from ER Ca2+ store. The decrease in the Ca2+ content of the ER is sensed by STIM1, which in turn activates SOCE in the
plasma membrane. Thus, the level of cytosolic Ca2+ is increased through release of Ca2+ from the ER Ca2+ store as well as Ca2+ influx via SOCE.
Receptors endogenous to HEK293 cells include: chemokine receptor; muscarinic acetylcholine receptor; glutamate receptor; B2-bradykinin
receptor; and P2X, P2Y purinergic receptors [10]; these represent candidates for interaction with Echinacea constituents. PLC: phospholipase C;
IP3, inositol-1,4,5-trisphosphate; PIP2: phosphatidylinositol-4,5-bisphosphate; IP3R: IP3 receptor; ER: endoplasmic reticulum; STIM1: stromal
interaction molecule 1; SOCE: store-operated calcium entry.
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cytokine signaling activities of various immune cells,
both of which are involved in many steps of immuno-
modulatory responses and mediation of pain transmis-
sion [4,11,19]. Consistent with this concept, microarray
analyses indicate that Echinacea preparations modulate
the levels of varied cytokine transcripts in human acute
monocytic leukemia cells, bronchial epithelial cells and
dendritic cells [29-31]. The overall transcript profiles in
these microarray experiments are diverse, although it is
not clear as to whether this variation is associated with
the use of different cell models or different Echinacea
preparations. Taken together, these studies and our own
convey the important message that Echinacea may
induce many responses in various cell types involving
more than one signaling pathway, and that it is a combi-
nation of these responses that likely lead to the overall
physiological effect on the organism.
This report highlights the effect of lipophilic, non-
alkamide Echinacea components in a non-immune-
related cell type that lacks CB2 receptors. Our use of a
human non-immune cell line as an experimental system
to evaluate Echinacea-induced response emphasizes the
complex effects of herbal medicines, and sheds more
light on potential molecular early signaling mechanisms
for this important medicinal plant. Thus the non-CB-
related intracellular calcium signaling induced by non-
alkamide components of Echinacea extracts revealed in
this study, in conjunction with the activation of CB-
mediated signaling by Echinacea extracts by specific
alkamides [6-8], provides an intriguing example of how
the chemical complexity of a single medicinal species
can affect diverse signaling receptors and pathways in a
cell-type dependent manner.
Conclusions
In conclusion, we show that extracts from Echinacea
induce transient increases of cytosolic Ca2+ levels when
applied to HEK293 cells, and that this increase can be
attributed to a subset of lipohilic Echinacea constituents.
HPLC fractionation reveals six distinct lipophilic frac-
tions that induce this transient increase in cytosolic Ca2+.
This bioactivity does not appear to be attributable to any
known bioactive components of Echinacea, including the
alkamides. Furthermore, it is not associated with the CB
receptors. Based on studies with a range of inhibitors,
activators and experimental conditions, we propose that
Echinacea extract contains compounds other than its
known alkamides that induce cytosolic Ca2+ release, in
combination with an ER-depletion-associated activation
of the SOCE pathway in HEK293 cells.
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